Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

Clicks: 214
ID: 273483
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Thus, even children receiving anticancer chemotherapy may have a mild or asymptomatic course of COVID-19. While we should not underestimate the risk of developing a more severe course of COVID-19 than that observed here, the intensity of preventive measures should not cause delays or obstructions in …
Reference Key
o2020europeanflash Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hrusak O;Kalina T;Wolf J;Balduzzi A;Provenzi M;Rizzari C;Rives S;Del Pozo Carlavilla M;Alonso MEV;Domínguez-Pinilla N;Bourquin JP;Schmiegelow K;Attarbaschi A;Grillner P;Mellgren K;van der Werff Ten Bosch J;Pieters R;Brozou T;Borkhardt A;Escherich G;Lauten M;Stanulla M;Smith O;Yeoh AEJ;Elitzur S;Vora A;Li CK;Ariffin H;Kolenova A;Dallapozza L;Farah R;Lazic J;Manabe A;Styczynski J;Kovacs G;Ottoffy G;Felice MS;Buldini B;Conter V;Stary J;Schrappe M;;
Journal European journal of cancer (Oxford, England : 1990)
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32305831
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE covid-19 sars-cov-2 humans pubmed abstract nih national institutes of health national library of medicine pandemics female male adolescent Child Surveys and Questionnaires pneumonia neoplasms / complications viral / drug therapy neoplasms / drug therapy* betacoronavirus* coronavirus infections / complications* coronavirus infections / drug therapy viral / complications* antineoplastic agents / therapeutic use* pmid:32305831 pmc7141482 doi:10.1016/j.ejca.2020.03.021 ondrej hrusak tomas kalina martin schrappe

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.